In addition, in a recent work from our research group using a yeast-based p53-MDM2 interaction assay, combined with assays in HCT116 human tumor cells, the ability of PC2 to disrupt the p53-MDM2 interaction was established [20]. The gene discussed is MDM2; the disease is neoplasm.